Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Filings indexed 916 across all filing types
Latest filing 2024-01-24 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting dated 24 January, 2024
Regulatory Filings
2024-01-24 English
Outcome of Board Meeting
Regulatory Filings
2024-01-24 English
Board Meeting — WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 24-Jan-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quart…
Regulatory Filings
2024-01-12 English
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 ,inter alia, to consider and approve Notice is hereby given pursuant to ....
Regulatory Filings
2024-01-12 English
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 ,inter alia, to consider and approve Notice is hereby given pursuant to ....
Regulatory Filings
2024-01-12 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is very short (751 characters) and contains no substantive financial data, analysis, or detailed report content. It appears to be a digitally signed statement or certification by an individual named Jitendra Jayantilal Gandhi, with no indication of financial results, management changes, or other report types. Given the brevity and nature of the content, it fits the criteria for a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings such as officer certifications or attestations.
2024-01-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.